ADMA Biologics
ADMA
ADMA
213 hedge funds and large institutions have $1.16B invested in ADMA Biologics in 2024 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 85 increasing their positions, 54 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
48% more capital invested
Capital invested by funds: $782M → $1.16B (+$373M)
16% more funds holding
Funds holding: 184 → 213 (+29)
0.15% more ownership
Funds ownership: 76.53% → 76.69% (+0.15%)
Holders
213
Holding in Top 10
6
Calls
$3.04M
Puts
$93K
Top Buyers
| 1 | +$22.6M | |
| 2 | +$17.2M | |
| 3 | +$11.2M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$11.1M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$7.96M |
Top Sellers
| 1 | -$38.3M | |
| 2 | -$24.8M | |
| 3 | -$12.7M | |
| 4 |
Millennium Management
New York
|
-$11.5M |
| 5 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$10.7M |